Contact this trialFirst, we need to learn more about you.
NCX 470 for Glaucoma
Recruiting0 awardsPhase 2 & 3
Rochester, Minnesota
This trial uses an eye drop solution called NCX 470, a nitric oxide (NO)-donating bimatoprost, to study its effects on eye fluid movement in healthy individuals and those with high eye pressure.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service